These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 26133231)

  • 1. Treatment of resistant influenza virus infection in a hospitalized patient with cystic fibrosis with DAS181, a host-directed antiviral.
    Silveira FP; Abdel-Massih R; Bogdanovich T; Pakstis DL; Routh RL; Moss RB
    Antivir Ther; 2016; 21(1):71-4. PubMed ID: 26133231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent oseltamivir-resistant pandemic influenza A/H1N1 infection in an adult with cystic fibrosis.
    Flight WG; Bright-Thomas R; Mutton K; Webb K; Jones A
    BMJ Case Rep; 2011 Apr; 2011():. PubMed ID: 22696672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of oseltamivir and zanamivir resistance in influenza A(H1N1)pdm09 virus, Denmark, 2014.
    Trebbien R; Pedersen SS; Vorborg K; Franck KT; Fischer TK
    Euro Surveill; 2017 Jan; 22(3):. PubMed ID: 28128091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection and viral load kinetics of an oseltamivir-resistant pandemic influenza A (H1N1) virus in an immunocompromised patient during treatment with neuraminidase inhibitors.
    Antón A; López-Iglesias AA; Tórtola T; Ruiz-Camps I; Abrisqueta P; Llopart L; Marcos MÁ; Martínez MJ; Tudó G; Bosch F; Pahissa A; de Anta MT; Pumarola T
    Diagn Microbiol Infect Dis; 2010 Nov; 68(3):214-9. PubMed ID: 20955912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oseltamivir-induced resistant pandemic A/H1N1 influenza virus in a child with cystic fibrosis and Pseudomonas aeruginosa infection.
    Esposito S; Molteni CG; Colombo C; Daleno C; Daccò V; Lackenby A; Principi N
    J Clin Virol; 2010 May; 48(1):62-5. PubMed ID: 20335065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel pandemic influenza A(H1N1) viruses are potently inhibited by DAS181, a sialidase fusion protein.
    Triana-Baltzer GB; Gubareva LV; Nicholls JM; Pearce MB; Mishin VP; Belser JA; Chen LM; Chan RW; Chan MC; Hedlund M; Larson JL; Moss RB; Katz JM; Tumpey TM; Fang F
    PLoS One; 2009 Nov; 4(11):e7788. PubMed ID: 19893747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuraminidase Activity and Resistance of 2009 Pandemic H1N1 Influenza Virus to Antiviral Activity in Bronchoalveolar Fluid.
    Ruangrung K; Suptawiwat O; Maneechotesuwan K; Boonarkart C; Chakritbudsabong W; Assawabhumi J; Bhattarakosol P; Uiprasertkul M; Puthavathana P; Wiriyarat W; Jongkaewwattana A; Auewarakul P
    J Virol; 2016 May; 90(9):4637-4646. PubMed ID: 26912622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pathway of influenza pan-neuraminidase inhibitor resistance in an immunocompromised patient.
    Abed Y; Schibler M; Checkmahomed L; Carbonneau J; Venable MC; Fage C; Giannotti F; Goncalves AR; Kaiser L; Boivin G
    Antivir Ther; 2019; 24(8):581-587. PubMed ID: 32031540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of Multidrug-Resistant Influenza A(H1N1)pdm09 Virus Variants in an Immunocompromised Child Treated With Oseltamivir and Zanamivir.
    Tamura D; DeBiasi RL; Okomo-Adhiambo M; Mishin VP; Campbell AP; Loechelt B; Wiedermann BL; Fry AM; Gubareva LV
    J Infect Dis; 2015 Oct; 212(8):1209-13. PubMed ID: 25943200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of the rapid emergence of the H275Y mutation associated with oseltamivir resistance in severe pandemic influenza virus A/H1N1 09 infections.
    Wang B; Dwyer DE; Blyth CC; Soedjono M; Shi H; Kesson A; Ratnamohan M; McPhie K; Cunningham AL; Saksena NK
    Antiviral Res; 2010 Jul; 87(1):16-21. PubMed ID: 20385168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A two-year survey of the oseltamivir-resistant influenza A(H1N1) virus in Yamagata, Japan and the clinical effectiveness of oseltamivir and zanamivir.
    Matsuzaki Y; Mizuta K; Aoki Y; Suto A; Abiko C; Sanjoh K; Sugawara K; Takashita E; Itagaki T; Katsushima Y; Ujike M; Obuchi M; Odagiri T; Tashiro M
    Virol J; 2010 Mar; 7():53. PubMed ID: 20202225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral treatment and virological monitoring of oseltamivir-resistant influenza virus A(H1N1)pdm09 in a patient with chronic B lymphocytic leukemia.
    Salata C; Sgarabotto D; Del Vecchio C; Solimbergo E; Marini G; Nicolè S; Franchin E; Parolin C; Calistri A; Palù G
    J Infect Chemother; 2019 Jul; 25(7):543-546. PubMed ID: 31014561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fatal pneumonitis due to oseltamivir-resistant new influenza A(H1N1) in the case of an intensive care patient].
    Aardema H; Tulleken JE; van den Biggelaar RJ; Wolters BA; de Jager CM; Boucher CA; Riezebos-Brilman A
    Ned Tijdschr Geneeskd; 2010; 154():A1634. PubMed ID: 20482913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical management and viral genomic diversity analysis of a child's influenza A(H1N1)pdm09 infection in the context of a severe combined immunodeficiency.
    Pichon M; Picard C; Simon B; Gaymard A; Renard C; Massenavette B; Malcus C; Monneret G; Morfin-Sherpa F; Valette M; Javouhey E; Millat G; Lina B; Josset L; Escuret V
    Antiviral Res; 2018 Dec; 160():1-9. PubMed ID: 30315875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence of pandemic influenza H1N1 virus in young patients after oseltamivir therapy in the 2009-2010 season: a comparison with seasonal H1N1 with or without H275Y mutation.
    Kawai N; Ikematsu H; Iwaki N; Kondou K; Hirotsu N; Kawashima T; Maeda T; Tanaka O; Doniwa K; Iwakuni O; Egashira K; Yamaji K; Kashiwagi S
    J Infect Chemother; 2012 Apr; 18(2):180-6. PubMed ID: 22193710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primarily oseltamivir-resistant influenza A (H1N1pdm09) virus evolving into a multidrug-resistant virus carrying H275Y and I223R neuraminidase substitutions.
    Grund S; Gkioule C; Termos T; Pfeifer N; Kobbe G; Verheyen J; Adams O
    Antivir Ther; 2015; 20(1):97-100. PubMed ID: 24941247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oseltamivir-resistant 2009 H1N1 influenza pneumonia during therapy in a renal transplant recipient.
    Shetty AK; Ross GA; Pranikoff T; Gubareva LV; Sechrist C; Guirand DM; Abramson J; Lin JJ
    Pediatr Transplant; 2012 Aug; 16(5):E153-7. PubMed ID: 22764830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of intravenous zanamivir after development of oseltamivir resistance in a critically Ill immunosuppressed child infected with 2009 pandemic influenza A (H1N1) virus.
    Dulek DE; Williams JV; Creech CB; Schulert AK; Frangoul HA; Domm J; Denison MR; Chappell JD
    Clin Infect Dis; 2010 Jun; 50(11):1493-6. PubMed ID: 20415572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influenza A, will it keep on mutating?].
    Olea-Jiménez V; Mora-Ordóñez JM; Rodríguez-Díez A; Calbo-Torrecillas F
    Med Intensiva; 2012; 36(1):64. PubMed ID: 22197172
    [No Abstract]   [Full Text] [Related]  

  • 20. Oseltamivir-resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009-2010.
    Meijer A; Jonges M; Abbink F; Ang W; van Beek J; Beersma M; Bloembergen P; Boucher C; Claas E; Donker G; van Gageldonk-Lafeber R; Isken L; de Jong A; Kroes A; Leenders S; van der Lubben M; Mascini E; Niesters B; Oosterheert JJ; Osterhaus A; Riesmeijer R; Riezebos-Brilman A; Schutten M; Sebens F; Stelma F; Swaan C; Timen A; van 't Veen A; van der Vries E; te Wierik M; Koopmans M
    Antiviral Res; 2011 Oct; 92(1):81-9. PubMed ID: 21767571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.